The high levels of MRPS30-DT in breast cancer patients are positively correlated with poor prognosis, and knocking down MRPS30-DT in the breast cancer cell significantly inhibits cell proliferation and invasion and induces apoptosis (38), suggesting its potential as a prognostic biomarker and therapeutic target. Here, MRPS30 is linked to breast carcinoma.